{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"autosomal-dominant-hyperinsulinism-due-to-sur1-deficiency","columns":[{"gene":"","key":"population-6589f4b8255301c5525b","label":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","mondoId":"MONDO:0017184","onsetQualifier":null,"originColumnKey":"MONDO:0017184/ORPHA:276575","originalViews":[{"key":"MONDO:0017184/ORPHA:276575","label":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","scopeLabel":"ORPHA:276575","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["024cc2a08c96adcb5511a38b137306cafde528349ff6faebb4fc5b1972f6c2dc","034489530e1241abbbc0161acdc67cac0737a57b194ab2e15d396b813770a9fc","090cf9e8b595eb42be56b0ed667af16da324e899640bd10a0435a28ee6a6b868","1601fe841c698eca3d4cc1023e6f011ccee917b279ac2e22fea01685ce7b17ca","2d373916dc8d1c1afdb885fe45b45d4f3d9fb80615316637368b67d189a121aa","2e62db045eae7176033e884c8c12e524a9caf6dae9bfcf8500deaf4eb9702c8e","4310e4a01e8672a59126853ae46a0f2acc27d829404aa4bf8f627ad7c68b9cd4","437cf28c6140e0b8121d63298deb5238bd8d12076a62886475cbc8aaf39e7449","4747d770e71fcdbc34659ba48f87987055107132e63c6c22f7157dbf556f09ae","496522b4de885381ddbfc922c4243c04af3c54e3e4ff8d2d2e605d58802449ea","4985775e075e20ca6256d59d4c9a905fb317cc1ac27523da485fedb32a768cf6","5a169460f223e553679c2c59bf609f40c7b172019272a1f92972272366300220","6d126dd7fa6a06580d000403008d49a2cdfed7c27306641f33dac427a7edf8f2","6db404ef5f1550e25b6f94dad9e1c9dc5d39ef80ae2b146c17ef2e16f28ac8f8","716e630597df85ae84cdbc60a7230ed1205fd7b73a6433d58dfa88ff6311108d","7baeb95c28c0f626d6af3261e6b5634e9698a15ae680b6cff655a5c11143422e","85d431e55cad2286762d94d0a12131e484a0a9edcde50a6a93230d21cb58cec5","9a4539845b200ba104f3f69055c34f6bb988cb9649bd73999a62a81f9796b020","9aad58dda953d20bcbfa61d301a1825d973df41d6e532f5da42ad7035ff8c089","9d9814d40f2854481cdb64387379844d1b58e2d5cb1a7ba5432c4f92be1abd21","a8c4d8bc348c16dce169f740d57470867bb13e4062c381b0d9d269235239f13c","c72197b0b62b4295140778e7c031bb26fb071ff700382e07f106656018ca95b7","c80e37996d0b5c371ad05347945089da02cc2876822f79c1811524b54680cd37","e01bff7c530178d34a3ef68083ed24cc5d95b7b367a885a614445d642d0f009f","ee21954759f5d893f34e0672c1090ac644ed05124640a5b6c3a565d09a370a86","f2f5ed2c0549038cfe964ae03d93668bdee88da4e9a7e4378fb92159ee9378b6","f650395dedec6f1b077cb5f5e3782b7ed6b877a1acdf7fa15881681695abadc8","fb4685ecc4ad935d9a2b26c58df7ffaa23b29d5605137a750a9c9455e0f0864c"],"recordQualifiers":{},"scopeLabel":"ORPHA:276575","sourceIds":["ORPHA:276575"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-6589f4b8255301c5525b"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000713","HP:0040299","HP:0031224","HP:0002329","HP:0030796","HP:0001069","HP:0031084"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":28,"sourceGroups":{"orphanet":28}},"features":[{"hpoId":"HP:0000713","label":"Agitation","primary":true},{"hpoId":"HP:0040299","label":"Decreased circulating free fatty acid level","primary":true},{"hpoId":"HP:0031224","label":"Diffuse pancreatic islet hyperplasia","primary":true},{"hpoId":"HP:0002329","label":"Drowsiness","primary":true},{"hpoId":"HP:0030796","label":"Elevated circulating C-peptide concentration","primary":true},{"hpoId":"HP:0001069","label":"Episodic hyperhidrosis","primary":true},{"hpoId":"HP:0031084","label":"Excessive insulin response to glucagon test","primary":true},{"hpoId":"HP:0003162","label":"Fasting hypoglycemia","primary":false},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":false},{"hpoId":"HP:0031223","label":"Focal pancreatic islet hyperplasia","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0000842","label":"Hyperinsulinemia","primary":false},{"hpoId":"HP:0000825","label":"Hyperinsulinemic hypoglycemia","primary":false},{"hpoId":"HP:0001639","label":"Hypertrophic cardiomyopathy","primary":false},{"hpoId":"HP:0001325","label":"Hypoglycemic coma","primary":false},{"hpoId":"HP:0002173","label":"Hypoglycemic seizures","primary":false},{"hpoId":"HP:0001985","label":"Hypoketotic hypoglycemia","primary":false},{"hpoId":"HP:0001520","label":"Large for gestational age","primary":false},{"hpoId":"HP:0001254","label":"Lethargy","primary":false},{"hpoId":"HP:0007185","label":"Loss of consciousness","primary":false},{"hpoId":"HP:0012759","label":"Neurodevelopmental abnormality","primary":false},{"hpoId":"HP:0000980","label":"Pallor","primary":false},{"hpoId":"HP:0001962","label":"Palpitations","primary":false},{"hpoId":"HP:0002591","label":"Polyphagia","primary":false},{"hpoId":"HP:0002133","label":"Status epilepticus","primary":false},{"hpoId":"HP:0001279","label":"Syncope","primary":false},{"hpoId":"HP:0001649","label":"Tachycardia","primary":false},{"hpoId":"HP:0100651","label":"Type I diabetes mellitus","primary":false}],"ledeHtml":"A form of congenital diazoxide-sensitive diffuse hyperinsulinism due to ABCC8 variants and characterized by hypoglycemic episodes that are usually mild, escaping detection during infancy, and usually have a good clinical response to diazoxide. The autosomal dominant hyperinsulinism usually has a milder phenotype when compared to that resulting from recessive potassium (K-ATP) channel mutations.","mondoId":"MONDO:0017184","node":{"canonicalSlug":"autosomal-dominant-hyperinsulinism-due-to-sur1-deficiency","comparisons":[{"documentSha256":"694c1a6d64dc5380af3aeb2b7a6f4cd02838442544e7be9faa4339e1e2b1ece2","key":"legacy-hyperinsulinemic-hypoglycemia","kind":"legacy","label":"hyperinsulinemic hypoglycemia","memberIds":["MONDO:0005803","MONDO:0009734","MONDO:0011153","MONDO:0011236","MONDO:0011717","MONDO:0012381","MONDO:0012382","MONDO:0012396","MONDO:0016988","MONDO:0017183","MONDO:0017184","MONDO:0017185","MONDO:0017189","MONDO:0017935","MONDO:0018465","MONDO:0019334","MONDO:0859362"],"mondoId":"MONDO:0005803","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hyperinsulinemic-hypoglycemia.694c1a6d64dc5380af3aeb2b7a6f4cd02838442544e7be9faa4339e1e2b1ece2.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","originalSourceId":"ORPHA:276575","paragraphs":["A form of congenital diazoxide-sensitive diffuse hyperinsulinism due to ABCC8 variants and characterized by hypoglycemic episodes that are usually mild, escaping detection during infancy, and usually have a good clinical response to diazoxide. The autosomal dominant hyperinsulinism usually has a milder phenotype when compared to that resulting from recessive potassium (K-ATP) channel mutations."],"rawAttribution":"MONDO:0017184","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:42:19Z","upstream":"MONDO:0017184","url":"https://rarediseases.info.nih.gov/diseases/17283"},"ownColumnKeys":["population-6589f4b8255301c5525b"],"publication":"published","relationships":[{"kind":"parent","label":"diazoxide-sensitive diffuse hyperinsulinism","mondoId":"MONDO:0015624","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"024cc2a08c96adcb5511a38b137306cafde528349ff6faebb4fc5b1972f6c2dc","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002173","is_excluded":false,"label":"Hypoglycemic seizures","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"034489530e1241abbbc0161acdc67cac0737a57b194ab2e15d396b813770a9fc","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000842","is_excluded":false,"label":"Hyperinsulinemia","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"090cf9e8b595eb42be56b0ed667af16da324e899640bd10a0435a28ee6a6b868","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001639","is_excluded":false,"label":"Hypertrophic cardiomyopathy","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1601fe841c698eca3d4cc1023e6f011ccee917b279ac2e22fea01685ce7b17ca","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000825","is_excluded":false,"label":"Hyperinsulinemic hypoglycemia","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2d373916dc8d1c1afdb885fe45b45d4f3d9fb80615316637368b67d189a121aa","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000980","is_excluded":false,"label":"Pallor","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2e62db045eae7176033e884c8c12e524a9caf6dae9bfcf8500deaf4eb9702c8e","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0031084","is_excluded":false,"label":"Excessive insulin response to glucagon test","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4310e4a01e8672a59126853ae46a0f2acc27d829404aa4bf8f627ad7c68b9cd4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003162","is_excluded":false,"label":"Fasting hypoglycemia","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"437cf28c6140e0b8121d63298deb5238bd8d12076a62886475cbc8aaf39e7449","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002133","is_excluded":false,"label":"Status epilepticus","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4747d770e71fcdbc34659ba48f87987055107132e63c6c22f7157dbf556f09ae","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001649","is_excluded":false,"label":"Tachycardia","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"496522b4de885381ddbfc922c4243c04af3c54e3e4ff8d2d2e605d58802449ea","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002329","is_excluded":false,"label":"Drowsiness","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4985775e075e20ca6256d59d4c9a905fb317cc1ac27523da485fedb32a768cf6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007185","is_excluded":false,"label":"Loss of consciousness","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5a169460f223e553679c2c59bf609f40c7b172019272a1f92972272366300220","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012759","is_excluded":false,"label":"Neurodevelopmental abnormality","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6d126dd7fa6a06580d000403008d49a2cdfed7c27306641f33dac427a7edf8f2","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030796","is_excluded":false,"label":"Elevated circulating C-peptide concentration","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6db404ef5f1550e25b6f94dad9e1c9dc5d39ef80ae2b146c17ef2e16f28ac8f8","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001962","is_excluded":false,"label":"Palpitations","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"716e630597df85ae84cdbc60a7230ed1205fd7b73a6433d58dfa88ff6311108d","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001520","is_excluded":false,"label":"Large for gestational age","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7baeb95c28c0f626d6af3261e6b5634e9698a15ae680b6cff655a5c11143422e","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0100651","is_excluded":false,"label":"Type I diabetes mellitus","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"85d431e55cad2286762d94d0a12131e484a0a9edcde50a6a93230d21cb58cec5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000713","is_excluded":false,"label":"Agitation","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9a4539845b200ba104f3f69055c34f6bb988cb9649bd73999a62a81f9796b020","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001279","is_excluded":false,"label":"Syncope","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9aad58dda953d20bcbfa61d301a1825d973df41d6e532f5da42ad7035ff8c089","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9d9814d40f2854481cdb64387379844d1b58e2d5cb1a7ba5432c4f92be1abd21","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001325","is_excluded":false,"label":"Hypoglycemic coma","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a8c4d8bc348c16dce169f740d57470867bb13e4062c381b0d9d269235239f13c","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c72197b0b62b4295140778e7c031bb26fb071ff700382e07f106656018ca95b7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002591","is_excluded":false,"label":"Polyphagia","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c80e37996d0b5c371ad05347945089da02cc2876822f79c1811524b54680cd37","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031224","is_excluded":false,"label":"Diffuse pancreatic islet hyperplasia","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e01bff7c530178d34a3ef68083ed24cc5d95b7b367a885a614445d642d0f009f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001254","is_excluded":false,"label":"Lethargy","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ee21954759f5d893f34e0672c1090ac644ed05124640a5b6c3a565d09a370a86","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031223","is_excluded":false,"label":"Focal pancreatic islet hyperplasia","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f2f5ed2c0549038cfe964ae03d93668bdee88da4e9a7e4378fb92159ee9378b6","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001069","is_excluded":false,"label":"Episodic hyperhidrosis","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f650395dedec6f1b077cb5f5e3782b7ed6b877a1acdf7fa15881681695abadc8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0040299","is_excluded":false,"label":"Decreased circulating free fatty acid level","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fb4685ecc4ad935d9a2b26c58df7ffaa23b29d5605137a750a9c9455e0f0864c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:276575","disease_name":"Autosomal dominant hyperinsulinism due to SUR1 deficiency","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001985","is_excluded":false,"label":"Hypoketotic hypoglycemia","onset_id":null,"reference":"ORPHA:276575","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17283\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0017184\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0017184</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A form of congenital diazoxide-sensitive diffuse hyperinsulinism due to ABCC8 variants and characterized by hypoglycemic episodes that are usually mild, escaping detection during infancy, and usually have a good clinical response to diazoxide. The autosomal dominant hyperinsulinism usually has a milder phenotype when compared to that resulting from recessive potassium (K-ATP) channel mutations.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17283\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"autosomal-dominant-hyperinsulinism-due-to-sur1-deficiency","sourceDocuments":[{"name":"GARD: Autosomal dominant hyperinsulinism due to SUR1 deficiency","reviewed":null,"source_release":"2026-10-25T03:42:19Z","url":"https://rarediseases.info.nih.gov/diseases/17283"},{"name":"MONDO: autosomal dominant hyperinsulinism due to SUR1 deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0017184"}],"sourceNote":"","synonyms":["autosomal dominant hyperinsulinemic hypoglycemia due to SUR1 deficiency"],"takeawayHtml":"","title":"autosomal dominant hyperinsulinism due to SUR1 deficiency"},"schemaVersion":1}
